The pharmaceutical industry faces increasing pressure to develop complex therapeutics under ever tighter regulatory scrutiny. Elemental impurities can halt programs late in development, uncharacterized bioanalytical risks may undermine safety assessments, and advanced modalities like metallodrugs demand tools capable of providing reliable data at trace levels. Traditional LC–MS workflows, while powerful, cannot fully address these challenges. Failure to adopt the right analytical strategies early on risks costly delays, failed regulatory submissions, or missed opportunities in competitive pipelines.
In this webinar, we will demonstrate how Inductively Coupled Plasma Mass Spectrometry (ICP-MS) provides unmatched sensitivity and specificity for detecting and quantifying trace elements in complex biological matrices. You will gain insight into real case studies—ranging from pharmacokinetics of metal-based drugs, measurement of endogenous biomarkers, to speciation studies—that highlight how ICP-MS addresses key bioanalytical hurdles.
Attendees will also learn how Arcinova integrates ICP-MS into end-to-end bioanalytical services. We will discuss practical workflows, method validation under GLP/GCP, and strategies for overcoming contamination and matrix interferences. By the end of the session, you will understand how to apply these approaches to strengthen your company’s bioanalytical strategy, improve regulatory confidence, and accelerate decision-making.
Don’t miss this opportunity to discover how ICP-MS can help you stay ahead of the analytical challenges shaping drug development. Register today to secure your place and learn how our expertise can help you bring innovative medicines to patients faster and with greater confidence.
Key Learning Objectives
- Understand the unique capabilities of ICP-MS in bioanalysis and how it addresses limitations of traditional LC–MS approaches for trace element detection.
- Recognize key applications of ICP-MS in drug development, including pharmacokinetics of metallodrugs, endogenous biomarker measurement, and speciation analysis.
- Learn practical strategies for implementing ICP-MS workflows—covering sample preparation, matrix interference management, and regulatory-compliant method validation.
- Apply ICP-MS insights to strengthen bioanalytical strategies in your own organization, reducing development risks, improving regulatory confidence, and accelerating project timelines.
